Ann: Q4 2021 quarterly activity and cash flow report, page-33

First 33 Last

Share
Profile

Follow
Wasabibarako

13,050 Posts.

788

21/02/22

20:33

Post #: 59716297
Share

Originally posted by Wasabibarako: ↑

aurel19672003: Thanks for a very excellent post !

aurel19672003: "- a personal opinion, I may be wrong, is that FDA would approve an NDA submitted by a US pharma easier than submitted by a foreign minnow pharma company..."
I FULLY AGREE with this comment - there must be a natural kind of "bias" in favour of the local heavyweights... Some of the FDA staff come from big US PHARMA companies were they worked before.
This leads to your - in my view quite LOGICAL - conclusion about the best way forward for NNZ 2591:

aurel19672003: "I would prefer NEU to partner with a BIG US PHARMA for P3 trial in US for NNZ 2591 rather than go it alone..."

All the aforementioned purely JIMHO, of course!

Once again: Many thanks, "aurel19672003" !

wasa

Expand

Sorry - a quick follow-up question: WHICH US Big Pharma companies are involved/interested in that "rare diseases" field that NEUREN is involved in? I do know that PFIZER is one of them... Who are the others? Thanks in advance!

wasa

NEU Price at posting: $3.94 Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

ASX Market Open: Oz shares to see out tumultuous FY24-25 with green day | June 30

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

AII

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

First 33 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $14.20		Change 0.890(6.69%)		Mkt cap ! $1.761B

Open	High	Low	Value	Volume
$13.50	$14.26	$12.96	$9.111M	655.8K

Buyers (Bids)

No.	Vol.	Price($)
1	2000	$14.17

Sellers (Offers)

Price($)	Vol.	No.
$14.23	3278	1

View Market Depth

No.	Vol.	Price($)
1	1300	14.030
1	500	14.000
1	357	13.970
1	30	13.900
1	700	13.700

Price($)	Vol.	No.
14.260	2920	1
14.300	1000	1
14.380	72	1
14.400	1000	1
14.460	434	1

Last trade - 16.15pm 27/06/2025 (20 minute delay)

NEU (ASX) Chart

Ann: Q4 2021 quarterly activity and cash flow report, page-33

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

ASX Market Open: Oz shares to see out tumultuous FY24-25 with green day | June 30

Australia’s gas crisis is here – and dying coal plants aren’t helping

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Q4 2021 quarterly activity and cash flow report, page-33

Top Stories

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

ASX Market Open: Oz shares to see out tumultuous FY24-25 with green day | June 30

Australia’s gas crisis is here – and dying coal plants aren’t helping

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News